MX9204791A - Dibenz (b,f,)oxazepil-11(1oh)-onas para agentes indibenz (b,f,)oxazepil-11(1oh)-onas para agentes inversores de la resistencia a multiples drogas. versores de la resistencia a multiples drogas. - Google Patents

Dibenz (b,f,)oxazepil-11(1oh)-onas para agentes indibenz (b,f,)oxazepil-11(1oh)-onas para agentes inversores de la resistencia a multiples drogas. versores de la resistencia a multiples drogas.

Info

Publication number
MX9204791A
MX9204791A MX9204791A MX9204791A MX9204791A MX 9204791 A MX9204791 A MX 9204791A MX 9204791 A MX9204791 A MX 9204791A MX 9204791 A MX9204791 A MX 9204791A MX 9204791 A MX9204791 A MX 9204791A
Authority
MX
Mexico
Prior art keywords
oxazepil
resistance
agents
multiple drugs
indibenz
Prior art date
Application number
MX9204791A
Other languages
English (en)
Inventor
Ivo Monkovic
Lotte Wang
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9204791A publication Critical patent/MX9204791A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/04—Seven-membered rings having the hetero atoms in positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
MX9204791A 1991-08-26 1992-08-19 Dibenz (b,f,)oxazepil-11(1oh)-onas para agentes indibenz (b,f,)oxazepil-11(1oh)-onas para agentes inversores de la resistencia a multiples drogas. versores de la resistencia a multiples drogas. MX9204791A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/749,741 US5173486A (en) 1991-08-26 1991-08-26 Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents

Publications (1)

Publication Number Publication Date
MX9204791A true MX9204791A (es) 1993-01-01

Family

ID=25014983

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204791A MX9204791A (es) 1991-08-26 1992-08-19 Dibenz (b,f,)oxazepil-11(1oh)-onas para agentes indibenz (b,f,)oxazepil-11(1oh)-onas para agentes inversores de la resistencia a multiples drogas. versores de la resistencia a multiples drogas.

Country Status (22)

Country Link
US (1) US5173486A (es)
EP (1) EP0529386B1 (es)
JP (1) JP3136427B2 (es)
KR (1) KR100204119B1 (es)
CN (1) CN1038749C (es)
AT (1) ATE149158T1 (es)
AU (1) AU642602B2 (es)
CA (1) CA2075861C (es)
DE (1) DE69217594T2 (es)
DK (1) DK0529386T3 (es)
ES (1) ES2097841T3 (es)
FI (1) FI112656B (es)
GR (1) GR3022698T3 (es)
HK (1) HK1005029A1 (es)
HU (1) HU214584B (es)
IL (1) IL102542A (es)
MX (1) MX9204791A (es)
NO (2) NO301586B1 (es)
PL (1) PL168707B1 (es)
RU (1) RU2086545C1 (es)
TW (1) TW213905B (es)
ZA (1) ZA925287B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP2149372B1 (en) * 2008-07-31 2014-04-02 Universität Ulm Use of opioids of the methadone group for the treatment of resistant cancer patients
CN104016937B (zh) * 2014-05-09 2016-12-07 中科院广州化学有限公司 一种n-芳基氧氮杂卓酮类化合物及其制备方法
WO2019173761A1 (en) 2018-03-09 2019-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546214A (en) * 1967-07-11 1970-12-08 Boehringer Sohn Ingelheim Amino-substituted dibenz(b,f)(1,4)oxazepin-11(10h)-ones

Also Published As

Publication number Publication date
NO923049L (no) 1993-03-01
NO923049D0 (no) 1992-08-03
CA2075861A1 (en) 1993-02-27
DK0529386T3 (da) 1997-07-28
NO972247D0 (no) 1997-05-16
ATE149158T1 (de) 1997-03-15
CN1069731A (zh) 1993-03-10
JP3136427B2 (ja) 2001-02-19
RU2086545C1 (ru) 1997-08-10
HU214584B (hu) 1998-04-28
FI923285A0 (fi) 1992-07-17
DE69217594D1 (de) 1997-04-03
ZA925287B (en) 1993-04-28
GR3022698T3 (en) 1997-05-31
AU2074292A (en) 1993-03-04
PL295633A1 (en) 1993-03-08
KR100204119B1 (ko) 1999-06-15
AU642602B2 (en) 1993-10-21
FI112656B (fi) 2003-12-31
DE69217594T2 (de) 1997-10-02
CN1038749C (zh) 1998-06-17
NO301586B1 (no) 1997-11-17
US5173486A (en) 1992-12-22
TW213905B (es) 1993-10-01
HUT63837A (en) 1993-10-28
KR930004281A (ko) 1993-03-22
IL102542A (en) 1995-12-31
FI923285A (fi) 1993-02-27
IL102542A0 (en) 1993-01-14
JPH05194442A (ja) 1993-08-03
PL168707B1 (pl) 1996-03-29
NO972247L (no) 1997-05-16
ES2097841T3 (es) 1997-04-16
HU9202319D0 (en) 1992-10-28
HK1005029A1 (en) 1998-12-18
NO309603B1 (no) 2001-02-26
CA2075861C (en) 2003-08-05
EP0529386A1 (en) 1993-03-03
EP0529386B1 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
MX9204791A (es) Dibenz (b,f,)oxazepil-11(1oh)-onas para agentes indibenz (b,f,)oxazepil-11(1oh)-onas para agentes inversores de la resistencia a multiples drogas. versores de la resistencia a multiples drogas.
BR9205172A (pt) Composto,processo para a preparacao do mesmo,processo para combater fungos em um local,composicao fungicida e uso
NO932873D0 (no) 9-((substituerte glycyl)amido)-6-dementyl-6-deoksotetrasykliner
DK0582788T3 (da) 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner
NO932871D0 (no) Nye 7-(substituerte)-8-(substituerte)-9-((substituerte glycyl)amido)-6-demetyl-6-deoksytetracykliner
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
SE9100920D0 (sv) New active compounds
ES2168189B1 (es) Derivados de piperazinona
DE69600714D1 (de) Antiallergische Zusammensetzung enthaltend eine Phosphorsäurediester-Verbindung
ATE136536T1 (de) Derivate von bis(phenyl)äthan
ATE134371T1 (de) Fungizide furanonderivate
TH13552EX (th) อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน